About The Vascular Anomalies Center (VAC) "Hemangioma"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at The Vascular Anomalies Center (VAC) "Hemangioma"
During the past decade, The Vascular Anomalies Center (VAC) "Hemangioma" conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at The Vascular Anomalies Center (VAC) "Hemangioma"
According to Clinical.Site data, the most researched conditions in "The Vascular Anomalies Center (VAC) "Hemangioma"" are
"Beta Blocker Toxicity" (1 trials), "Capillary Malformation-Arteriovenous Malformation" (1 trials), "Port-Wine Stain" (1 trials), "Spinal Hemangioma" (1 trials) and "Spinal Tumor" (1 trials). Many other conditions were trialed in "The Vascular Anomalies Center (VAC) "Hemangioma"" in a lesser frequency.
Clinical Trials Intervention Types at The Vascular Anomalies Center (VAC) "Hemangioma"
Most popular intervention types in "The Vascular Anomalies Center (VAC) "Hemangioma"" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atenolol Pill" (1 trials), "Haemoblock" (1 trials), "Placebo" (1 trials) and "Propranolol Pill" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The Vascular Anomalies Center (VAC) "Hemangioma"
The vast majority of trials in "The Vascular Anomalies Center (VAC) "Hemangioma"" are
2 trials for "All" genders.
Clinical Trials Status at The Vascular Anomalies Center (VAC) "Hemangioma"
Currently, there are NaN active trials in "The Vascular Anomalies Center (VAC) "Hemangioma"".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 1 completed trials in The Vascular Anomalies Center (VAC) "Hemangioma",
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in The Vascular Anomalies Center (VAC) "Hemangioma", 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".